Concepedia

Patricia Ogilvie

PO

Statistics

Publications

23

Citations

947

H-Index

17

Active since

1995

Affiliations

Allergan (United States)(Current)

Advantagene (United States)

Rosenpark Klinik

University of British Columbia

University of California, Los Angeles

Patricia Ogilvie is an author at Allergan (United States) specializing in medicine, pharmacotherapy, and facial aesthetic assessment.

Publications per year

1995–2023

23

Publications

23

Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5

Patricia Ogilvie, Giuseppe Bardi, Ian Clark‐Lewis et al. · Blood · 2001 · 187 citations

Medicine, Immunology, Pharmacology +5

Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes

Patricia Ogilvie, Samantha Paoletti, Ian Clark‐Lewis et al. · Blood · 2003 · 112 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Induction and variants of neuronal nitric oxide synthase type I during synaptogenesis

Patricia Ogilvie, Karl Schilling, Melvin L. Bllllngslev et al. · The FASEB Journal · 1995 · 105 citations

Life Sciences, Neurobiology, Neuroscience +13

Safe, Effective Chin and Jaw Restoration With VYC-25L Hyaluronic Acid Injectable Gel

Patricia Ogilvie, Gerhard Sattler, Frodo Gaymans et al. · Dermatologic Surgery · 2019 · 62 citations

Dentistry, Maxillofacial Surgery, Oral Medicine +14

VYC-25L Hyaluronic Acid Injectable Gel Is Safe and Effective for Long-Term Restoration and Creation of Volume of the Lower Face

Patricia Ogilvie, Laurence Benouaiche, Wolfgang G. Philipp‐Dormston et al. · Aesthetic Surgery Journal · 2020 · 52 citations · Full text

Medicine, Surgery, Oral Tissue Regeneration +14

1–5 of 23